Jan 30 (Reuters) - Madrigal Pharmaceuticals Inc:
* MADRIGAL ANNOUNCES ACCEPTANCE OF MGL-3196 ABSTRACT FOR A MAIN PLENARY PRESENTATION AT THE INTERNATIONAL LIVER CONGRESSâ„¢ 2018 Source text for Eikon: Further company coverage:
 